|
|||||
|
|
||||||
Erratum
for
Huguet et al., © 2009 American Society of Clinical Oncology. DOI: 10.1200/JCO.2009.23.1985 ERRATUMThe February 20, 2009, article by Huguet et al, entitled, "Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study" (J Clin Oncol 27:911–918, 2009), contained errors in Table 1.Under "Remission induction," the term "corticosteroid prophase" was given, whereas it should have been "corticosteroid prephase." The dose for L-asparaginase was given as, "6,000 U/m2/d on days 8, 10, 12, 18, 20, 22, 24, and 26," and it should have been, "6,000 U/m2/d on days 8, 10, 12, 20, 22, 24, 26, and 28." Also, the dose for cyclophosphamide (CPM) was given as, "750 mg/m2/d on days 1 and 8; 750 mg/m2 on day 15 in good early responders; 500 mg/m2/12 h on days 15 and 16 in poor early responders," and should have been, "750 mg/m2/d on day 1; 750 mg/m2/d on day 15 in good early responders; 500 mg/m2/12 h on days 15 and 16 in poor early responders." Under "Consolidation blocks 3, 6, and 9," the dose for CPM was given as, "500 mg/m2 on days 29 and 30," and should have been, "500 mg/m2/d on days 29 and 30." Also, the dose for VP-16 was given as, "75 mg/m2m/d on days 29 and 30," and should have been "75 mg/m2/d on days 29 and 30." Under "Late intensification (between consolidation blocks 6 and 7)," the dose for lenograstim was not indicated for patients in complete remission after the first induction course, and should have been, "150 µg/m2/d if neutrophils < 0.5 G/L to myeloid recovery." Under "Maintenance therapy," the dose for prednisone (PDN) was given as, "40 mg/m2/d on days 1-14 monthly for 12 months," and should have been, "40 mg/m2/d on days 1-7 monthly for 12 months." Under "CNS therapy, Treatment of patients with initial CNS involvement," the dose for triple IT injects was given as, "Eight between days 7 and 21 of induction; four during the first two consolidation blocks; one at day 29 of consolidation blocks 3 and 6," and should have been, "Eight between days -7 and 21 of induction; four during the first two consolidation blocks; one at day 29 of consolidation blocks 3 and 6." Also, the dose for cranial irradiation was given as, "15 Gy before SCT or 18 Gy before late intensification; 6-MP 60 mg/m2/d during irradiation," and should have been, "15 Gy before SCT or 24 Gy before maintenance therapy initiation; 6-MP 60 mg/m2/d during irradiation." Also under "CNS therapy," the footnote for triple IT injections was given as:
While it should have been:
The online version has been corrected in departure from the print.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|